Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human RPS6KA5 Stable Cell Line

    [CAT#: S01YF-1023-PY13]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Kinase Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Based on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.

    Sub Cat Product Name Target Protein Species Host Cell Type Assay Types Inquiry Datasheet
    S01YF-1122-KX1230 Magic™ Human MSK1(RPS6KA5) in Vitro Assay Human Kinase Assay

    Product Information

    Target Family
    Kinases/Enzyme
    Target Protein Species
    Human
    Host Cell Type
    HEK293;CHO-K1;MEF
    Target Classification
    Kinase Cell Lines
    Target Research Area
    CNS Research;Ocular Research
    Related Diseases
    Joubert Syndrome 28; Coffin-Lowry Syndrome
    Gene ID
    Human:9252
    UniProt ID
    Human:O75582

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    RPS6KA5, also known as ribosomal protein S6 kinase A5, has been implicated in various biological processes and diseases. In the context of male infertility, RPS6KA5 has been identified as one of the genes potentially responsible for disturbed spermatogenesis and nonobstructive azoospermia (NOA). Activation of the ESX1 gene, including RPS6KA5, using CRISPRa technology in human germ cells showed significantly higher expression levels of RPS6KA5 in modified cells compared to wild-type cells, indicating its potential role in male infertility. In the field of placental function and metabolic analysis, RPS6KA5 was found to be differentially expressed in hyperglycemic-exposed BeWo trophoblast cells. It was also identified as one of the potential prognostic markers in esophageal adenocarcinoma, where low expression of RPS6KA5 was associated with increased overall survival. Additionally, RPS6KA5 methylation was found to be a predictor of response to treatment in adolescent patients with major depressive disorder. Finally, in colorectal cancer, RPS6KA5 was identified as one of the parental genes of m6A modified circRNAs and showed potential prognostic value for CRC patients. These findings suggest that RPS6KA5 may have diverse roles and implications in male infertility, placental function, esophageal adenocarcinoma, major depressive disorder, and colorectal cancer.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human RPS6KA5 Stable Cell Line (S01YF-1023-PY13). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Alex Miller (Verified Customer)

    Can RPS6KA5 methylation levels predict treatment response in depression? May 07 2022

    chat Patrick Liam (Creative Biolabs Scientific Support)

    Yes, methylation of the RPS6KA5 gene can predict remission after six weeks of treatment in adolescent patients with major depressive disorder (MDD). May 07 2022

    chat Peyton Garcia (Verified Customer)

    What is the significance of RPS6KA5 in chronic childhood stress and depression? Feb 11 2023

    chat Patrick Liam (Creative Biolabs Scientific Support)

    While chronic childhood stress is associated with an increased risk of depression, it does not appear to interact with RPS6KA5 methylation in influencing treatment response. Feb 11 2023

    Published Data

    Fig.1 Knockdown of Msk1 (RPS6KA5) in MEF cells.

    In the analysis of Msk1 and Msk2, mock-transfected (Con) and Msk1 knockdown (KD) MEFs were subjected to Western analysis. Actin served as the loading control and was utilized to quantify the degree of Msk1 knockdown, which was found to be 1% of the control. A representative western blot from a set of three is provided.

    Ref: Wiersma, Maaike, et al. "Protein kinase Msk1 physically and functionally interacts with the KMT2A/MLL1 methyltransferase complex and contributes to the regulation of multiple target genes." Epigenetics & Chromatin 9 (2016): 1-12.

    Pubmed: 27895715

    DOI: 10.1186/s13072-016-0103-3

    Research Highlights

    Malcher, Agnieszka. et al. "ESX1 gene as a potential candidate responsible for male infertility in nonobstructive azoospermia." Scientific reports, 2023.
    The problem of infertility affects approximately 15% of couples, with male infertility being responsible for 40-50% of these cases. The causes of male infertility are still not well understood and effective treatment methods are lacking. One of the main causes of male infertility is disturbed spermatogenesis, leading to nonobstructive azoospermia (NOA). To better understand the role of the ESX1 gene in NOA, the study aimed to activate the gene using CRISPRa technology in human germ cells (testicular seminoma cells-TCam-2). Results showed successful activation of the ESX1 gene, with significantly increased expression levels in modified TCam-2 cells compared to wild-type cells or negative controls with nontargeted gRNA. Additionally, RNA-seq analysis identified a network of over 50 genes potentially regulated by ESX1. Verification through gene expression analysis in azoospermic patients with and without a mutation in ESX1 as well as those with normal spermatogenesis showed correlations between the levels of ESX1 and 6 genes related to cell proliferation and differentiation.
    Malcher, Agnieszka. et al. "ESX1 gene as a potential candidate responsible for male infertility in nonobstructive azoospermia." Scientific reports, 2023.
    Pubmed: 37783880   DOI: 10.1038/s41598-023-43854-9

    J W Easton, Zachary. et al. "The impact of hyperglycemia upon BeWo trophoblast cell metabolic function: A multi-OMICS and functional metabolic analysis." PloS one, 2023.
    Recent studies have linked pre-existing and gestationally-developed diabetes mellitus with impairments in placental villous trophoblast cell metabolic function, which may contribute to the development of metabolic diseases in exposed offspring. Using placental cell lines and ex vivo trophoblast preparations, previous research has identified hyperglycemia as a significant independent regulator of placental function. However, the direct effects of hyperglycemia on specific aspects of placental metabolism, such as nutrient storage and mitochondrial respiration, remain poorly understood. This study aimed to further characterize these effects by examining metabolic and mitochondrial function, as well as nutrient storage, in both undifferentiated cytotrophoblast and differentiated syncytiotrophoblast BeWo cells cultured under hyperglycemic conditions. Results showed increased glycogen and triglyceride nutrient stores in hyperglycemic-exposed BeWo trophoblasts, but no changes in real-time functional readouts of metabolic enzyme activity and mitochondrial respiratory activity. Further investigation into mitochondrial dynamics revealed increased expression of markers associated with mitochondrial fission, indicating a potential transition towards mitochondrial dysfunction in high-glucose exposed trophoblasts. A multi-omics approach was then used to evaluate the transcriptomic and metabolomic signatures of BeWo cytotrophoblasts exposed to hyperglycemia, which showed changes in the expression of genes related to glucose, glutathione, fatty acid, and glucocorticoid metabolism, as well as alterations in specific metabolite levels. These findings highlight the role of hyperglycemia as an independent regulator of various aspects of placental metabolism, nutrient storage, and mitochondrial function, providing further insights into the mechanisms behind placental dysfunction.
    J W Easton, Zachary. et al. "The impact of hyperglycemia upon BeWo trophoblast cell metabolic function: A multi-OMICS and functional metabolic analysis." PloS one, 2023.
    Pubmed: 36930661   DOI: 10.1371/journal.pone.0283118

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare